Obtaining the necessary funding when you want to commercialize an academic idea and build a startup is a huge challenge, especially if you don’t know where to start. Following the wrong path can mean the difference between success or wasted time.
Programme
Learn more about what to consider when you are seeking funding that will bring your ideas to the market from two experienced life science professionals.
Erling Nordbø 
CEO at Aleap
Erling has 18 years experience from global pharmaceutical and biotech companies. He has also worked with a large range of Norwegian health startups, everything from pharma to digital health solutions.
Over the last 6 years he has been leading Aleap in Oslo Science Park, a national incubator for health startups.
Erling holds an MBA from ESCP Business School.
Adam Robertson 
CSO and Co-founder at Hemispherian
Adam has a strong background in biochemistry, molecular biology and the study of cellular processes. He holds a PhD in Biology from University of North Carolina at Chapel Hill, USA.
After earning his doctorate, Adam spent almost 12 years as a postdoc and later a scientific group leader at Oslo University Hospital.
His scientific work led to discoveries that led to the foundation of Hemispherian, an Oslo based pharmaceutical startup advancing anti-cancer drugs that target the DNA Damage response. Hemispherian has been successful at raising capital from public and private sources, including family offices, national and international venture capital firms.
Digital attendance
If you are unable to attend at Forskningsparken, but will be able to attend digitally, please send an email to Torunn to get a separate registration link for zoom-participation. Please note that we encourage physical participation for the best experience of the meeting.